Abstract
Activation-induced cell death (AICD) is an active process. T and B lymphocytes undergo AICD as an auto-regulatory mechanism for the body to remove unwanted activated cells after making appropriate use of them. Recent studies have shown that brain microglia and astrocytes also undergo apoptosis upon inflammatory activation. Caspase-11 has been demonstrated to play a central role in the apoptosis of both microglia and astrocytes following inflammatory activation; inflammatory stimuli induce neuroglial apoptosis through caspases-11, -1, and -3. Thus, inflammatory signals that activate neuroglia may also initiate internal death program, in which caspases play a crucial role. Caspases may be a target for the modulation of neuroglial AICD that has implications in neurodegenerative diseases.
Keywords: apoptosis, caspase, microglia, astrocyte, nitric oxide, inflammation, signal transduction, neurodegenerative diseases
Current Enzyme Inhibition
Title: Role of Caspases in Activation-Induced Cell Death of Neuroglia
Volume: 1 Issue: 1
Author(s): Kyoungho Suk
Affiliation:
Keywords: apoptosis, caspase, microglia, astrocyte, nitric oxide, inflammation, signal transduction, neurodegenerative diseases
Abstract: Activation-induced cell death (AICD) is an active process. T and B lymphocytes undergo AICD as an auto-regulatory mechanism for the body to remove unwanted activated cells after making appropriate use of them. Recent studies have shown that brain microglia and astrocytes also undergo apoptosis upon inflammatory activation. Caspase-11 has been demonstrated to play a central role in the apoptosis of both microglia and astrocytes following inflammatory activation; inflammatory stimuli induce neuroglial apoptosis through caspases-11, -1, and -3. Thus, inflammatory signals that activate neuroglia may also initiate internal death program, in which caspases play a crucial role. Caspases may be a target for the modulation of neuroglial AICD that has implications in neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Suk Kyoungho, Role of Caspases in Activation-Induced Cell Death of Neuroglia, Current Enzyme Inhibition 2005; 1 (1) . https://dx.doi.org/10.2174/1573408052952757
DOI https://dx.doi.org/10.2174/1573408052952757 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Vitamin D : Autoimmunity and Gender
Current Medicinal Chemistry Vasorelaxation Caused by Cannabinoids: Mechanisms in Different Vascular Beds
Current Vascular Pharmacology Editorial [ Advances in Heme Oxygenase Research as a Potential Therapeutic Strategy Executive Editor: M.J. Alcaraz]
Current Pharmaceutical Design Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
Current Medicinal Chemistry Programmed Symptoms: Disparate Effects United by Purpose
Current Rheumatology Reviews Role of Estradiol and Progesterone in HIV Susceptibility and Disease Progression
Mini-Reviews in Medicinal Chemistry Protective Antiviral Antibodies that Lack Neutralizing Activity: Precedents and Evolution of Concepts
Current HIV Research Contribution of Spinal Cord Oligodendrocytes to Neuroinflammatory Diseases and Pain
Current Medicinal Chemistry Therapeutic Indications and Action Mechanisms of Bilirubin: Suggestions from Natural Calculus Bovis
Current Signal Transduction Therapy The Role of Angiotensin-Converting Enzyme in Immunity: Shedding Light on Experimental Findings
Endocrine, Metabolic & Immune Disorders - Drug Targets Cannabinoid Receptor Type 2 Activation Yields Delayed Tolerance to Focal Cerebral Ischemia
Current Neurovascular Research A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology Peptides Targeting Toll-Like Receptor Signalling Pathways for Novel Immune Therapeutics
Current Pharmaceutical Design The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Current Drug Metabolism The Role of Osteopontin in Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
Inflammation & Allergy - Drug Targets (Discontinued) Immunoadjunctive Therapy against Bacterial Infections Using Herbal Medicines Based on Th17 Cell-mediated Protective Immunity
Current Pharmaceutical Design The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Endogenous Ligand Bias by Chemokines: Implications at the Front Lines of Infection and Leukocyte Trafficking
Endocrine, Metabolic & Immune Disorders - Drug Targets Leukocyte Traffic Blockade as a Therapeutic Strategy in Inflammatory Bowel Disease
Current Drug Targets